Name | ISSN / ISBN | Publisher |
---|---|---|
Future Oncology | 14796694 | Charles Peterfy |
Future Oncology | 14796694 | The Authors |
Future Oncology | 1479-6694 | Gilead Sciences, Inc |
Future Oncology | 1479-6694 | Merck & Co |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Tanios Bekaii Saab |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 14796694 | Future Medicine |
Future Oncology | 14796694 | Informa Uk Limited, Trading As Taylor & Francis Group |
Future Oncology | 14796694 | Andrew Davies, University of Southampton |
Future Oncology | 1744-8301 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 14796694 | Seth H Jacobs |
Future Oncology | 14796694 | 2017 Future Medicine Ltd |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Seth H Jacobs |
Future Oncology | 14796694 | AbbVie Inc |
Future Oncology | 14796694 | Unknown |
Future Oncology | 14796694 | 2018 Future Medicine Ltd |
Future Oncology | 1479-6694 | Taylor & Francis Group |
Future Oncology | 1479-6694 | AbbVie Inc |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 1479-6694 | Future Medicine |
Future Oncology | 0890-9091 | Unknown |
Future Oncology | 1479-6694 | Unknown |
Future oncology (London, England) | 17448301 | Unknown |
Unknown (1479-6694) | 1479-6694 | Unknown |